IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM PAR
Total 13F shares
4,247,605
Share change
-1,873,992
Total reported value
$2,420,000
Put/Call ratio
0%
Price per share
$0.57
Number of holders
28
Value change
-$1,660,631
Number of buys
11
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q4 2021

As of 31 Dec 2021, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,247,605 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, HOLLENCREST CAPITAL MANAGEMENT, MORGAN STANLEY, STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, and NORTHERN TRUST CORP. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.